clinical trial · NCT07494409
A Study of AND017 to Evaluate Efficacy and Safety in Dialysis-Dependent Chronic Kidney Disease (DD-CKD) Patients With Anemia
Anemia Due to Chronic Kidney DiseaseAND017 capsulesESA
brief summary
This is a phase III, randomized, open-label, active-controlled study to evaluate the safety and efficacy of AND017 in anemic patients with End-Stage-Kidney-Disease (ESKD)
started
Oct 31, 2025
primary completion
Oct 30, 2026
completion
Apr 30, 2027
last updated
Mar 27, 2026
official title
A Phase 3, Multi-center, Randomized, Open-Label, Active-Controlled, Efficacy and Safety Study of AND017 to Treat Anemia in Dialysis-Dependent Chronic Kidney Disease (DD-CKD) Patients With Anemia
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol